For example, Karimi et al. screened the capacity of Magnetic Activated Cell Sorting (MACS) to identify CTCs in the blood of treatment-naive BC patients in various stages using EpCam and a panel of cytokeratins (CK) for detection (CK7, CK8, CK18, and CK19) [131]. This evidence concerns the gene KRT19 and breast cancer.